• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐万古霉素粪肠球菌的体外药敏研究。

In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis.

作者信息

Sahm D F, Kissinger J, Gilmore M S, Murray P R, Mulder R, Solliday J, Clarke B

机构信息

Clinical Microbiology Laboratory, University of Chicago, Illinois 60637-1463.

出版信息

Antimicrob Agents Chemother. 1989 Sep;33(9):1588-91. doi: 10.1128/AAC.33.9.1588.

DOI:10.1128/AAC.33.9.1588
PMID:2554802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC172707/
Abstract

Vancomycin resistance exhibited by Enterococcus faecalis isolates V583, V586, and V587 is described. The vancomycin MICs ranged from 32 to 64 micrograms/ml. Although resistant to vancomycin, the isolates were susceptible to teicoplanin (MIC, less than or equal to 0.5 micrograms/ml). Such a glycopeptide susceptibility profile has not been previously described for E. faecalis. Time kill studies showed that vancomycin resistance adversely affected the synergistic activity that vancomycin and aminoglycoside combinations usually demonstrate against enterococci. However, the ability to detect vancomycin resistance varied with the susceptibility testing method used. Whereas broth microdilution, broth macrodilution, and agar dilution methods detected resistance, disk-agar diffusion and the AutoMicrobic system Gram-Positive GPS-A susceptibility card (Vitek Systems Inc., Hazelwood, Mo.) did not. To detect vancomycin resistance reliably and establish the incidence of such E. faecalis isolates, adjustments in some susceptibility testing methods may be necessary.

摘要

描述了粪肠球菌分离株V583、V586和V587所表现出的万古霉素耐药性。万古霉素的最低抑菌浓度(MIC)范围为32至64微克/毫升。尽管这些分离株对万古霉素耐药,但它们对替考拉宁敏感(MIC小于或等于0.5微克/毫升)。这种糖肽类药敏谱此前尚未在粪肠球菌中描述过。时间杀菌研究表明,万古霉素耐药性对万古霉素和氨基糖苷类药物联合通常表现出的针对肠球菌的协同活性有不利影响。然而,检测万古霉素耐药性的能力因所使用的药敏试验方法而异。肉汤微量稀释法、肉汤常量稀释法和琼脂稀释法能检测到耐药性,而纸片琼脂扩散法和自动微生物系统革兰氏阳性GPS - A药敏卡(Vitek系统公司,密苏里州黑兹尔伍德)则不能。为了可靠地检测万古霉素耐药性并确定此类粪肠球菌分离株的发生率,可能需要对一些药敏试验方法进行调整。

相似文献

1
In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis.耐万古霉素粪肠球菌的体外药敏研究。
Antimicrob Agents Chemother. 1989 Sep;33(9):1588-91. doi: 10.1128/AAC.33.9.1588.
2
Comparison of agar dilution, broth microdilution, E-test, disk diffusion, and automated Vitek methods for testing susceptibilities of Enterococcus spp. to vancomycin.用于检测肠球菌属对万古霉素敏感性的琼脂稀释法、肉汤微量稀释法、E试验、纸片扩散法及Vitek自动化方法的比较。
J Clin Microbiol. 1997 Dec;35(12):3258-63. doi: 10.1128/jcm.35.12.3258-3263.1997.
3
Underestimation of vancomycin and teicoplanin MICs by broth microdilution leads to underdetection of glycopeptide-intermediate isolates of Staphylococcus aureus.肉汤微量稀释法低估万古霉素和替考拉宁 MIC 值会导致金黄色葡萄球菌糖肽中介体分离株漏检。
Antimicrob Agents Chemother. 2010 Sep;54(9):3861-70. doi: 10.1128/AAC.00269-10. Epub 2010 Jun 14.
4
European Glycopeptide Susceptibility Survey of gram-positive bacteria for 1995. European Glycopeptide Resistance Survey Study Group.1995年革兰氏阳性菌的欧洲糖肽敏感性调查。欧洲糖肽耐药性调查研究组。
Diagn Microbiol Infect Dis. 1998 Aug;31(4):563-71. doi: 10.1016/s0732-8893(98)00053-4.
5
Proficiency of Italian clinical laboratories in detecting reduced glycopeptide susceptibility in Enterococcus and Staphylococcus spp. using routine laboratory methodologies.意大利临床实验室运用常规实验室方法检测肠球菌和葡萄球菌属中糖肽敏感性降低情况的能力。
Clin Microbiol Infect. 2002 Feb;8(2):101-11. doi: 10.1046/j.1469-0691.2002.00378.x.
6
In vitro activity of the new glycopeptide decaplanin.
Eur J Clin Microbiol Infect Dis. 1992 May;11(5):458-62. doi: 10.1007/BF01961864.
7
Comparative in vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD127,391 against blood isolates of gram-positive cocci.替考拉宁、达托霉素、雷莫拉宁、万古霉素和PD127,391对革兰氏阳性球菌血液分离株的体外活性比较
Antimicrob Agents Chemother. 1992 Jul;36(7):1570-2. doi: 10.1128/AAC.36.7.1570.
8
In vitro detection of enterococcal vancomycin resistance.肠球菌对万古霉素耐药性的体外检测
Antimicrob Agents Chemother. 1990 Sep;34(9):1846-8. doi: 10.1128/AAC.34.9.1846.
9
Factors influencing the vitek gram-positive susceptibility system's detection of vanB-encoded vancomycin resistance among enterococci.影响Vitek革兰氏阳性菌药敏系统检测肠球菌中vanB编码的万古霉素耐药性的因素。
J Clin Microbiol. 1996 Mar;34(3):701-6. doi: 10.1128/jcm.34.3.701-706.1996.
10
Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.达托霉素(LY 146032)与四种对照抗生素单独及联合使用时,对庆大霉素敏感和高水平庆大霉素耐药肠球菌的体外抑制和杀菌活性比较。
Chemotherapy. 1993 Sep-Oct;39(5):302-9. doi: 10.1159/000239141.

引用本文的文献

1
Streptococcal natural products mediate interspecies competition with Gram-positive bacterial pathogens.链球菌天然产物介导与革兰氏阳性病原菌的种间竞争。
bioRxiv. 2025 Jul 31:2025.07.31.667707. doi: 10.1101/2025.07.31.667707.
2
Exploring the Potential of Phytocannabinoids Against Multidrug-Resistant Bacteria.探索植物大麻素对抗多重耐药细菌的潜力。
Plants (Basel). 2025 Jun 20;14(13):1901. doi: 10.3390/plants14131901.
3
Antimycobacterial activity of the plectasin derivative NZ2114.plecatan菌素衍生物NZ2114的抗分枝杆菌活性。
Front Microbiol. 2025 Jun 26;16:1613241. doi: 10.3389/fmicb.2025.1613241. eCollection 2025.
4
Comparative and functional genomic analysis of foreign DNA defense mechanisms in .……中外源DNA防御机制的比较与功能基因组分析
Microbiol Spectr. 2025 Aug 5;13(8):e0028925. doi: 10.1128/spectrum.00289-25. Epub 2025 Jun 18.
5
The expanded immunoregulatory protease network in mosquitoes is governed by gene coexpression.蚊子中扩展的免疫调节蛋白酶网络受基因共表达调控。
Proc Natl Acad Sci U S A. 2025 May 6;122(18):e2425863122. doi: 10.1073/pnas.2425863122. Epub 2025 Apr 30.
6
Factors affecting CRISPR-Cas defense against antibiotic resistance plasmids harbored by laboratory model strains and clinical isolates.影响CRISPR-Cas对实验室模型菌株和临床分离株携带的抗生素抗性质粒防御作用的因素。
bioRxiv. 2025 Mar 10:2025.03.10.642232. doi: 10.1101/2025.03.10.642232.
7
Genome-wide analysis of genes that facilitate interspecies competition with .促进与……种间竞争的基因的全基因组分析。 (原文中“with”后面缺少具体内容)
J Bacteriol. 2025 Mar 20;207(3):e0043824. doi: 10.1128/jb.00438-24. Epub 2025 Feb 4.
8
Dynamic collateral sensitivity profiles highlight opportunities and challenges for optimizing antibiotic treatments.动态侧支敏感性概况突出了优化抗生素治疗的机遇与挑战。
PLoS Biol. 2025 Jan 8;23(1):e3002970. doi: 10.1371/journal.pbio.3002970. eCollection 2025 Jan.
9
Discovery of potential natural therapeutics targeting cell wall biosynthesis in multidrug-resistant Enterococcus faecalis: a computational perspective.针对多药耐药粪肠球菌细胞壁生物合成的潜在天然治疗药物的发现:计算视角。
Biol Direct. 2024 Nov 5;19(1):101. doi: 10.1186/s13062-024-00538-2.
10
Enterococcal-host interactions in the gastrointestinal tract and beyond.肠道及其他部位的肠球菌与宿主的相互作用。
FEMS Microbes. 2024 Sep 9;5:xtae027. doi: 10.1093/femsmc/xtae027. eCollection 2024.

本文引用的文献

1
Synergy of penicillin and gentamicin against Enterococci.青霉素与庆大霉素对肠球菌的协同作用。
J Infect Dis. 1971 Dec;124 Suppl:S207-9. doi: 10.1093/infdis/124.supplement_1.s207.
2
Susceptibility of group D streptococcus (enterococcus) to 21 antibiotics in vitro, with special reference to species differences.D组链球菌(肠球菌)对21种抗生素的体外敏感性,特别提及种间差异。
Am J Med Sci. 1969 Dec;258(6):416-30. doi: 10.1097/00000441-196912000-00006.
3
In vitro activity of ampicillin or vancomycin combined with gentamicin or streptomycin against enterococci.氨苄西林或万古霉素联合庆大霉素或链霉素对肠球菌的体外活性
Antimicrob Agents Chemother. 1973 Oct;4(4):383-7. doi: 10.1128/AAC.4.4.383.
4
Synergism of vancomycin-gentamicin and vancomycin-streptomycin against enterococci.万古霉素-庆大霉素及万古霉素-链霉素对肠球菌的协同作用。
Antimicrob Agents Chemother. 1973 Aug;4(2):120-4. doi: 10.1128/AAC.4.2.120.
5
Vancomycin-streptomycin synergism in enterococcal endocarditis.万古霉素与链霉素在肠球菌性心内膜炎中的协同作用。
JAMA. 1973 Jan 1;223(1):37-40.
6
In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic.新型环脂肽抗生素A21978C1的体外活性及作用机制
Antimicrob Agents Chemother. 1985 Mar;27(3):357-62. doi: 10.1128/AAC.27.3.357.
7
Recovery of resistant enterococci during vancomycin prophylaxis.万古霉素预防期间耐万古霉素肠球菌的恢复情况。
J Clin Microbiol. 1988 Jun;26(6):1216-8. doi: 10.1128/jcm.26.6.1216-1218.1988.
8
High-content aminoglycoside disks for determining aminoglycoside-penicillin synergy against Enterococcus faecalis.用于确定氨基糖苷类药物与青霉素对粪肠球菌协同作用的高含量氨基糖苷类药敏纸片
J Clin Microbiol. 1988 Feb;26(2):257-60. doi: 10.1128/jcm.26.2.257-260.1988.
9
Effects of medium and inoculum variations on screening for high-level aminoglycoside resistance in Enterococcus faecalis.培养基和接种物变化对粪肠球菌高水平氨基糖苷类耐药性筛选的影响
J Clin Microbiol. 1988 Feb;26(2):250-6. doi: 10.1128/jcm.26.2.250-256.1988.
10
Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study.耐庆大霉素粪肠球菌的医院感染。一项流行病学研究。
Ann Intern Med. 1987 May;106(5):687-91. doi: 10.7326/0003-4819-106-5-687.